Joinn Laboratories (China) Co Ltd

603127

Company Profile

  • Business description

    Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

  • Contact

    A5 Rongjing East Street
    Beijing Economic-Technological Development Area
    Beijing100176
    CHN

    T: +86 1067869966

    https://www.joinnlabs.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    2,652

Stocks News & Analysis

stocks

Wide moat ASX listed global leader keeps winning

Latest earnings show continued strength.
stocks

Competitive pressures highlight need to lower costs for big 4 bank

Market reacts positively to results.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,907.002.500.03%
CAC 408,170.090.000.00%
DAX 4023,876.55165.07-0.69%
Dow JONES (US)47,147.98309.24-0.65%
FTSE 1009,698.37109.31-1.11%
HKSE26,572.46500.57-1.85%
NASDAQ22,900.5930.230.13%
Nikkei 22550,376.53905.30-1.77%
NZX 50 Index13,464.46133.41-0.98%
S&P 5006,734.163.33-0.05%
S&P/ASX 2008,634.508.900.10%
SSE Composite Index3,990.4939.01-0.97%

Market Movers